Discontinued — last reported Q3 '22
Business Segments · Deferred revenue - noncurrent
Health & Science Technologies — Deferred revenue - noncurrent
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ3 2022
Last reportedQ3 2022Oct 26, 2022
Rolls up toContract Liabilities
How to read this metric
An increase indicates strong long-term customer commitment and visibility into future revenue streams beyond the current fiscal year.
Detailed definition
Represents payments received from customers for goods or services that are expected to be delivered or performed beyond...
Peer comparison
Used by companies with long-term service agreements or multi-year projects; peers with high-value capital equipment often report this.
Metric ID:
iex_segment_health_science_technologies_deferred_revenue_noncurrentHistorical Data
1 periods
| Q3 '22 | |
|---|---|
| Value | $14.70M |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is IDEX's health & science technologies — deferred revenue - noncurrent?
- IDEX (IEX) reported health & science technologies — deferred revenue - noncurrent of $14.70M in Q3 2022.
- What does health & science technologies — deferred revenue - noncurrent mean?
- Cash received from customers for work that will be completed more than a year from now.